— Know what they know.
Not Investment Advice

INLB OTC

Item 9 Labs Corp.
1W: -99.0% 1M: -99.0% 3M: -99.0% YTD: -99.0% 1Y: -99.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±4955.7%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $70181 mcap · 524M float · 0.0039% daily turnover

Balance Sheet Trends

Total Assets
$111M -5.2% ▼
5Y CAGR: +299.7%
Total Liabilities
$49M +59.0% ▲
5Y CAGR: +83.6%
Shareholders Equity
$62M -28.0% ▼
Cash & Investments
$86K -94.1% ▼
5Y CAGR: -0.3%
Total Debt
$28M +33.0% ▲
5Y CAGR: +120.8%
Net Debt
$28M +42.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$174K$21K$85K$1M$86K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$174K$21K$85K$1M$86K
Net Receivables$961K$437K$353K$1M$586K
Inventory$0$180K$2M$6M$2M
Other Current Assets$619K$2M$0$622K$68K
Total Current Assets$2M$3M$3M$11M$4M
Property, Plant & Equip.$1M$8M$9M$12M$22M
Goodwill & Intangibles$0$3M$9M$77M$70M
Long-Term Investments$100K$100K$241K$18M$8M
Other Non-Current Assets$249K$685K$241K$18M$15M
Total Non-Current Assets$2M$12M$18M$106M$107M
Total Assets$4M$14M$21M$117M$111M
— Liabilities —
Accounts Payable$721K$1M$2M$4M$6M
Short-Term Debt$25K$5M$6M$6M$20M
Deferred Revenue$0$0$0$120K$220K
Other Current Liabilities$17K$87K$3M$5M$6M
Total Current Liabilities$895K$7M$10M$15M$41M
Long-Term Debt$2M$0$2M$15M$7M
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$2M$3M$2M$16M$8M
Total Liabilities$895K$7M$13M$31M$49M
— Equity —
Common Stock$5K$6K$7K$11K$11K
Retained Earnings-$824K-$11M-$23M-$34M-$65M
Accumulated OCI-$67K-$0$0$0$0
Total Stockholders Equity$3M$7M$8M$86M$62M
Total Liabilities & Equity$4M$14M$21M$117M$111M
— Key Metrics —
Total Debt$25K$5M$8M$21M$28M
Net Debt-$149K$5M$8M$19M$28M
Total Investments$100K$100K$241K$18M$8M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms